FDA Warns Thermograms Are No Substitute for Mammograms

October 30, 2017 — The U.S. Food and Drug Administration (FDA) last week issued a release reminding patients that mammography is still the most effective breast cancer screening test. According to the agency, proper breast cancer screening lets healthcare providers check for cancer even before there may be signs and symptoms of the disease.

MedRay Imaging, a private imaging clinic in Vancouver, B.C., Canada, recently turned to Agfa HealthCare to advance its value-based care initiative by delivering the benefits of direct (digital) radiography (DR). This development supports the clinic's mission to optimize the experience and care of patients, provide a smooth, efficient workflow for clinicians, and enhance the hospital's productivity by making processes more efficient.

Current skin cancer diagnosis can last a number of weeks and be very upsetting. However, a new imaging system developed by a group of European scientists could dramatically speed up the process and reduce the need for debilitating sentinel-lymph node biopsies by placing real-time diagnosis in the hands of a dermatologist.

Breast Density Reporting Advances on National and State Levels

On the same day that Wisconsin state representatives introduced a new bill mandating patient notification of breast density, both chambers of Congress revived the national Breast Density and Mammography Reporting Act which was first drafted in 2013.

PowerLook Tomo Detection

iCAD Inc. announced that its PowerLook Tomo Detection has been named 2017 Product of the Year by the New Hampshire High Technology Council, a member-driven organization with a focus on advancing innovation throughout the State of New Hampshire.  Built on deep learning technology, PowerLook Tomo Detection is the first and only concurrent-read cancer detection solution for digital breast tomosynthesis (DBT), according to the company, engineered to make it possible for radiologists to detect breast cancer more efficiently.

October 27, 2017 — Carestream Health is demonstrating advanced imaging analytics software tools as part of its Clinical Collaboration Platform at the Machine Learning Showcase being held in conjunction with the 2017 Radiological Society of North America (RSNA) tradeshow, Nov. 26-Dec. 1 in Chicago.

The Michael J. Fox Foundation for Parkinson's Research (MJFF) and the Tau Consortium announced a funding partnership to accelerate development of novel positron emission tomography (PET) imaging tracers for the detection of the alpha-synuclein and tau proteins in the living brain.

October 27, 2017 — Racial/ethnic disparities in cancer survival in the U.S. are well documented, but the underlying causes are not well understood. To better explain disparities, researchers examined cancer survival by racial/ethnic group for 877,662 patients diagnosed with breast, prostate, colorectal or lung cancer between 2000–2013 using California Cancer Registry data.

A study that integrated robust smoking cessation programs into an organized low-dose computed tomography (LDCT) lung cancer screening program found that the inclusion of both interventions has the potential to decrease mortality rates while being relatively cost-effective. William Evans, M.D., of McMaster University in Canada presented these findings at the International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC), Oct. 15-18 in Yokohama, Japan.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now